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a  b  s  t  r  a  c  t
Several  epidemiological  studies  have  reported  the relation  between  chromium  exposure
(used in  different  industrial  processes)  and  cancer  risk.  Evidence  indicates  that  the  hexa-
valent form  is mutagenic  and carcinogenic.  Chemoprevention  has  emerged  as  a  good
strategy  for  reducing  the  risk  from  exposure  to heavy  metals.  There  is evidence  that  some
tetrapyrrols  such  as  protoporphyrin  IX  (PP-IX),  a porphyrin  without  a metal  center  and
which  is  a  precursor  of  hemoglobin  and  cytochrome,  acts  as  an  antioxidant  modulating
the  induction  of  antioxidant  enzymes.  The  present  study was  performed  to evaluate  their
antimutagenic  potential  of PP-IX  against  genetic  damage  induced  by chromium  trioxide
(CrO3). The  wing  spot  test  was  used.  Groups  of 48  h-old  larvae  were  pretreated  for 24  h
with  0, 0.69,  6.9,  or 69  mM  of PP-IX,  after  which  groups  of  larvae  were  fed  0.025–2.5 mM
CrO3 solution  in Drosophila  instant  medium.  The  results  indicated  that  the  lower  PP-IX
concentration  (0.69  mM)  signiﬁcantly  reduced  the  genetic  damage  induced  by all  CrO3
concentrations  tested.  In contrast,  6.9  and  69  mM  only  inhibited  the  damage  induced  byLow  doses
Tetrapyrrols
CrO3 2.5  mM.  Absence  of an  inhibitor  effect  of  PP-IX  against  20 Gy  gamma  rays  suggested
that  this  porphyrin  acted  primarily  by forming  complexes  with  chromium  at low  doses,
inactivating  its genotoxic  action  rather  than  capturing  or  inactivating  the  reactive  oxygen
species  generated  by  the  chromium.
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1. IntroductionExposure to environmental pollutants of anthropogenic
origin is associated with an important increase of chronic
degenerative diseases including cancer [1]. Although heavy
metals  are present naturally in soils, their contamination is
Abbreviations: PP-IX, protoporphyrin IX; ROS, reactive oxygen
species; SMART, Somatic Mutation and Recombination Test; CAT, catalase;
SOD, superoxide dismutase; ENU, N-nitroso-N-ethylurea.
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caused directly by industrial and mining activities. Metals
such  as Pb, Hg, Cd, As, Ce, and Cr are very harmful to
human health and to most living organisms. They are not
chemically or biologically degradable components which
accumulate in the soil. If additionally the metals are ﬁltered
in  groundwater, control is very difﬁcult and the metals
can  enter the food chain, either through drinking water
or  through consuming contaminated crops in agricultural
soils, becoming a potential health risk [2]. They have been
associated with diseases such as pneumonia, renal dysfunc-
tion,  emphysema, and bone cancer [3], as well as with an
impaired  nerve function system [4].
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Given this situation, the need arises to implement
trategies that will reduce the occurrence of degenerative
iseases. The ﬁrst, and the most obvious, is to avoid expo-
ure  of human beings to those agents that have the ability
o  modify the genetic material and, therefore, increase
he risk of diseases such as cancer. However, in practice
his is almost impossible since many of such agents are
ound  naturally in the atmosphere (as ultraviolet or ion-
zing  radiation), and others are products of the metabolism
f  innocuous compounds such as nitrates [5]. The second
lternative is to increase the consumption of substances
apable of preventing or reducing the adverse effects of
utagenic and carcinogenic agents. This strategy refers to
hemoprevention and it is deﬁned as the use of chemical
ompounds, especially those of natural origin that cause
nhibition or reversal of mutagenesis or carcinogenesis in
he  premalignant state [1].
Among heavy metals, chromium is considered one of the
ost  dangerous and the International Agency of Research
n  Cancer [6] recognized the carcinogenicity of this metal.
ne  of the biggest sources of Cr VI exposure is through the
elease  of particles during stainless steel solder [7,8]. Expo-
ure  pathways include the following: oral, respiratory, and
ermal  pathways [9]. Chromium has been reported to be
istributed  into the body through the bone marrow, lungs,
ymph  nodes, spleen, kidney, and liver [10,11]. The dan-
er  of this element is known to occur during the reduction
rocess of Cr (VI) to Cr (III), generating reactive oxygen
pecies (ROS) that interact with the genetic material and
re  able to induce various alterations, for example: sister
hromatid exchanges, chromosomal aberrations and cross-
inks  in double-stranded DNA [11]. Not only are workers
n  manufacturing industries exposed to chromium com-
ounds, but also the general public is exposed through
igarette smoke, automobile emissions, landﬁlls, and haz-
rdous  waste disposal sites [12].
Among the natural compounds with chemoprevention
roperties, porphyrins are aromatic heterocyclic macro-
ycles  derived from the porphine base structure. They are
onsidered promising mainly because of their low toxic-
ty.  These molecules have the ability to form complexes
irectly with planar polycyclic structures thereby preven-
ing  their interaction with DNA; however, tetrapyrroles can
lso  be interspersed in the molecule [10]. The antimuta-
enic activity of porphyrins containing some metal ion is
ue  to their antioxidant effect [13–15]. Protoporphyrin-
X is a molecule with no metal core, it comes from the
iosynthesis of 5-aminolevulinic acid and it is the immedi-
te  precursor of heme [16]. The toxic effect of PP-IX could
robably be due to the imbalance of the redox systems
n  the over production of ROS [17,18], which leads to an
ncrease  in lipid peroxidation, which in turn is the main
ause  of damage to the liver [19,20]. In rats of the CF1 strain,
P-IX  induced lipid peroxidation and increased the activ-
ty  of catalase (CAT) 30% after 2 h of administration while
he  superoxide dismutase (SOD) enzyme increased 24 h
fter  administration, yet peroxidation decreased after sev-
ral  doses of PP-IX [21]. Chronic treatment with PP-IX was
ecently  found to prolong the lifespan of a wild Drosophila
train. In contrast, half life was reduced in the Sod deﬁcient
train; these data provide information that PP-IX can act asports 1 (2014) 894–899 895
an  antioxidant and as a pro-oxidant [22]. Based on these
previous works, the aim of the present study was  to evalu-
ate  the antimutagenic capacity of PP-IX against the genetic
damage induced by CrO3 (VI), an agent that induces genetic
damage especially through ROS.
2. Materials and methods
Somatic  Mutation and Recombination Test (SMART): In
order  to test DNA damage, we performed the wing spot test
[23]  as follows: three-day-old mwh + /mwh + females and
ﬂr3/In (3LR), TM3, Bds males were mated for 2 h, then trans-
ferred  to an egg-laying surface. Oviposition was  restricted
to  a 2 h period so as to obtain more homogeneous samples
in  the age of individuals under test. Then 48 h-old larvae
were  collected by density gradient using a 20% sucrose
solution. They were subsequently washed with 24 ± 1 ◦C
tap  water and pretreated for 24 h in the dark, in ﬂasks
(1/4 L) with a paper ﬁlter (Whatman # 2), saturated with
PP-IX  0, 0.69, 6.9, or 69 mM dissolved in a 5% sucrose solu-
tion.  Distilled water was used for all solutions.
On completion of the pretreatment period, the larvae
were washed with tap water at 24 ± 1 ◦C. At this time,
aliquots of larvae from each pretreatment concentration
of PP-IX were treated with 0.025, 0.25, 1.25, 2.0, or 2.5 mM
CrO3 in plastic vials (9.5 cm height and 2.5 cm diameter)
with 1.5 g of Drosophila instant medium (formula 4-24 Car-
olina  Biol. Supply Co.). Experiments were carried out in
triplicate for each pretreated PP-IX solution and for each
treatment with CrO3 solution. All treatments were con-
ducted in the dark.
Upon  eclosion, organisms were ﬁxed in 70% alcohol
and the wings of the mwh  + /+ ﬂr3 ﬂies (i.e., non-Ser) were
mounted on slides for 40× microscopic analysis. The wings
were  examined to identify small single spots (one or two
cells),  large single spots (more than two cells) of either
mwh or ﬂr, and mwh-ﬂr twin spots. Single mwh spots
are expected to be produced following mutation at the
mwh  + locus or by an interchange between the mwh and
ﬂr3 loci succeeded by homozygosis for mwh. Single ﬂr3
spots may  arise by mutation at the ﬂr3+ locus or by dou-
ble  exchange. Twin spots are the result of an interchange
between the ﬂr3 and the centromere [23]. For a description
of  the mutants see Lindsley and Zimm [24].
All data for each group represent at least two  exper-
iments performed in triplicate. Results from the groups
treated with PP-IX and CrO3 were compared with the group
corresponding to each CrO3 concentration. The SMART sta-
tistical  program proposed by Frei and Würgler [25] was
used  to determine differences between treatments. The
criterion for signiﬁcance was set at p < 0.05.
Toxicity test: In order to quantify the toxicity pro-
voked by PP-IX and CrO3 by themselves, groups of ﬁfty
48h-old larvae mwh +/ + ﬂr3 were collected and treated
following the method described above using the same con-
centrations of PP-IX and CrO3. To evaluate toxicity of the
combined treatment of the different PP-IX concentrations,
we selected the highest CrO3 concentration (2.5 mM). Chi
square  test was used for statistical analysis at p < 0.05 level.
PP-IX  and CrO3 were purchased from Sigma Chemicals Co.
(St.  Louis, MO).
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Table  1
Spots  frequency induced in 48 h-larvae mwh +/ + ﬂr3 by different concentrations of chromium trioxide (VI).
Spots per wing (number of spots)
Treatment (mM)  Small single spots Large single spots Twin spots Total spots
CrO3 No. of wings (1–2 cells), m = 2 (>cells), m = 5 m = 5 m = 2
0 160 0.24 (39) 0.09 (14) 0.01 (1) 0.34 (54)
0.025 120 0.26 (31) − 0.04 (5) − 0.03 (4) i 0.33 (40) −
0.25  150 0.43 (64) + 0.11 (16) − 0.05 (8) + 0.59 (88) +
1.25  118 0.63 (74) + 0.36 (42) + 0.14 (16)+ 1.12 (132)+
2.0  80 0.81 (65) + 0.52 (42) + 0.45 (36)+ 1.79 (143)+
1.97 
egative2.5  120 2.87 (344) + 
Statistical diagnoses according to Frei and Würgler [25]: + = positive; − = n
levels:  alpha = beta = 0.05. One-side statistical test.
Treatment with gamma rays: To explore activity of
the  PP-IX as a radical scavenger, we collected 48 h-old
mwh  +/+ ﬂr3 larvae and pretreated them for 24 h with PP-
IX  following the method described above. On completion
of  the pretreatment, larvae from each concentration were
divided  into two groups, one of each group was  irradiated
with 20 Gy gamma  rays in a Transelektro LGI-01, Co-60 irra-
diator  with a dose rate of up to 1259.44 Gy/h; the other
larva served as control. After irradiation, larvae were put
into  a plastic vial with hydrated medium formula 4-24.
All  the vials were introduced into a culture room until the
development concluded. The wings analysis was done as
described  earlier.
3.  ResultsTable 1 shows the frequency of all kinds of spots induced
by  the different concentrations of CrO3. Statistical signif-
icant differences were found for all kinds of spots from
Table 2
Spots  frequency induced by chromium trioxide (VI) treatment in 48 h-larvae mw
Spots pe
Treatment (mM)  Small sin
PP-IX (+) CrO3 No. of wings (1-2 cel
Pretreatment with PP-IX 0.69 mM (Section 1)
0.69  120 0.33 
+0.025  80 0.16 
+0.25  80 0.30 
+1.25 80 0.41 
+  2.0 80 0.70 
+  2.5 120 0.57 
Pretreatment with PP-IX 6.9 mM (Section 2)
6.9  120 0.23 
+  0.025 40 0.26 
+  0.25 80 0.31 
+  1.25 80 0.51 
+  2.0 80 0.59 
+  2.5 120 0.64 
Pretreatment  with PP-IX 69 mM (Section 3)
69  160 0.51 
+  0.025 120 0.37 
+  0.25 120 0.32 
+  1.25 80 1.51 
+  2.0 80 1.10 
+  2.5 140 0.92 
Statistical diagnoses according to Frei and Würgler [25]: + = positive; − = negative
levels:  alpha = beta = 0.05. One-side statistical test. The comparisons were betwe
control included in Table 1. The signs indicated in the PP-IX concentration alone (236) + 2.11 (254)+ 6.95 (834)+
; w = weak positive; i = inconclusive; m = multiplication factor. Probability
0.25  mM and higher concentrations. Noticeably, the higher
concentration provoked a frequency of mutation that rep-
resents  20 times the frequency found in the control group.
Table  2 includes the results obtained with the pretreat-
ment of 0.69, 6.9, or 69 mM  of PP-IX and with the combined
treatment of PP-IX + CrO3: Sections 1, 2, and 3, respectively.
Comparison of the action of PP-IX alone indicated that only
69  mM doubled the basal mutation frequency.
The  statistical analysis comparing the combined treat-
ments with their respective positive control in Table 1
indicated that pretreatment with 0.69 mM of PP-IX caused
a  reduction in the frequency of all kinds of spots from
PP-IX + 0.025 mM CrO3, however, this reduction were not
statistically signiﬁcant for all kinds of spots. A statistically
signiﬁcant reduction was  found from PP-IX 0.69 + CrO3
0.25 mM,  which decreased the twin spots induced by
all  concentrations of CrO3 with the exception of the
PP-IX + 1.25 mM group. Pretreatment with PP-IX 6.9 mM
caused  only a slight reduction in the frequency of the
h+/+ﬂr3 pretreated 24 h with 0.69, 6.9 or 69 mM of PP-IX.
r wing (number of spots)
gle spots Large single spots Twin spots Total spots
ls), m = 2 (>cells), m = 5 m = 5 m = 2
(40) i 0.05 (6) − 0.03 (3) i 0.41 (49) −
(13)i 0.02i (2) i 0.02 (2) i 0.21 (17) i
(24)i 0.06 (5) − 0.01 (1) i 0.37 (30)+
(80)+ 0.10 (8) + 0.14 (11) − 0.65 (52)+
(56) − 0.32 (26) − 0.26 (21)+ 1.30 (103)+
(69)+ 0.32 (38) + 0.28 (33)+ 1.17 (140)+
(28) − 0.05 (6) − 0 (0) 0.28 (34) −
(8) i 0.08 − (3) − 0 (0) 0.28 (11) i
(25) i 0.14 (11) − 0.04 (3) i 0.49 (39) −
(41) − 0.37 (30) − 0.12 (9) − 1.00 (80) −
(47) + 0.31 (25) − 0.30 (24) − 1.20 (96)w
(77) + 0.32 (38) + 0.23 (28)+ 1.19 (143) +
(81) + 0.14 (23) − 0.01 (2) i 0.66 (106) +
(45) − 0.08 (10) − 0 (0) 0.46 (55) −
(39) − 0.08 (9) − 0.02 (2) i 0.42 (50) i
(121) − 0.56 (45) − 0.40 (32) − 2.47 (198) −
(87) − 0.60 (48) − 0.54 (43) − 2.22 (178) −
(129) + 0.46 (64) + 0.40 (56)+ 1.78 (249) +
; w = weak positive; i = inconclusive; m = multiplication factor. Probability
en each group: PP-IX + CrO3 concentration with the respective positive
are the results from comparisons with the negative control.
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Table 3
Toxicity of 48 h-old mwh+/+ﬂr3 larvae after the treatment for 24 h with
PP-IX, CrO3 or combined treatment.






0 500 420 ± 0.9 16
PP-IX
0.69 500 394 ± 1.7 21
6.9 500 447 ± 0.6 11
69 500 368 ± 0.5 26
CrO3
0.25 500 448 ± 0.3 10
2.0 500 325 ± 2.8 35*
2.5 500 194 ± 0.8 61*
PP-IX + CrO3
0.69 + 2.5 400 164 ± 1.2 59





























l69 + 2.5 500 230 ± 1.8 54
* Signiﬁcant to p < 0.05. Compared with control
** Signiﬁcant to p < 0.05. Compared with CrO3 2.5 mM
ifferent kinds of spots from the PP-IX + 0.25 mM group,
nd only a weak decrease with respect to damage caused
y  2.0 mM CrO3; however, this concentration of PP-IX plus
.5  mM CrO3 fell six times the frequency of total spots
nduced by the mutagen alone (2.5 mM).  Comparison of the
ffect  of pretreatment with the 69 mM concentration and
he  previous two concentrations indicated that the com-
ined  treatment PP-IX + CrO3 2.5 mM group decreased four
imes  the frequency of total spots induced by CrO3 alone.
Results of toxicity for different concentrations of PP-
X,  CrO3 (0.25, 2, and 2.5 mM)  combined treatments are
resented in Table 3. The analysis showed that PP-IX was
ontoxic  at the three concentrations tested compared to
he  control. CrO3 was toxic at 2 and 2.5 mM;  the latter
educed viability 45% over the control. In contrast the com-
ined  treatments reduced toxicity, but 69 PP-IX + 2.5 CrO3
ncreased viability 7% compared with the 2.5 mM CrO3 con-
rol  group. Table 4 presents the results obtained for somatic
utation when larvae were pretreated with different con-
entrations of PP-IX and then treated with 20 Gy of gamma
ays.  The results indicated that PP-IX in all tested concen-
rations had no effect on damage induced by gamma  rays..  Discussion
Cr [VI] is known to produce breaking in one or both
trands of DNA; DNA-DNA bonds; DNA cross-links with
able 4
pots  frequency induced in 48 h-old mwh +/+ ﬂr3 larvae pretreated 24 h with di
amma  rays.
Treatment Spots per wing (number of spots)
PP-IX (mM)  + 20 Gy No. of Small single spots Large si
wings (1-2 cells), m = 2 (>cells),
0 40 0.27 (11) 0.05 
20  Gy 80 0.70 (56) 1.57 
0.69  + 80 0.82 (66) − 1.16 
6.9  + 80 0.69 (55) − 1.84 
69  + 80 1.16 (93) − 1.52 
tatistical diagnoses according to Frei and Wüergler [25]: + = positive; − = negative
evels:  alpha = beta = 0.05. One-side statistical test.ports 1 (2014) 894–899 897
proteins,  besides modifying the nucleotides as is the case
of  guanine, 8-hydroxyguanine links. Although the mecha-
nisms  involved are not yet very clear, all DNA alterations
can cause chronic degenerative diseases, including cancer
[26].
Genetic  damage induced by chromium is mainly pro-
duced as a result of its ability to induce free radicals,
especially during the reduction from Cr [VI] to Cr [III].
Such radicals are the superoxide anion (O2−), and hydroxyl
radical (OH•) [27]. To counteract the action of ROS, cells
have  a system of endogenous enzymes such as SOD and
CAT  and the glutathione as antioxidants. Furthermore,
exogenous antioxidants such as vitamins may  reduce the
cellular  damage caused by free radicals. The main sub-
ject  of the present study was  to evaluate the antioxidant
capacity of PP-IX avoiding the genetic damage induced by
CrO3. There is evidence that the antioxidant action of this
tetrapyrrol depends on its concentration [21,28,29]. The
results  obtained in our study provided evidence of this
effect:  PP-IX was  not toxic by itself (Table 3) and concen-
trations of 0.69 and 6.9 mM did not induce genetic damage,
yet  the 6.9 mM reduced total spots (p < 0.05) compared
to control and also reduced toxicity 5% but not signiﬁ-
cantly (Table 3) suggesting that protoporphyrin can act
as  a true antimutagen. Moreover, the highest concentra-
tion (69 mM)  proved to be mutagenic and induced damage
comparable with 0.25 mM of CrO3. In agreement with this,
PP-IX  has been proven to induce oxidative stress [21] via
production of superoxide ions and more efﬁciently of sin-
glet  oxygen in organic solutions [30]. Our results are in
accord  with this ﬁnding. Pimentel et al. [31] found that this
pigment  at 69 mM can be mutagenic 24 h after its adminis-
tration in combination with 0.5 mM N-nitroso-N-ethylurea
(ENU) and that such activity may  persist for 72 h. However,
the  evidence found in this study indicated that in organisms
pretreated with PP-IX and subsequently treated with CrO3,
the  frequency of genetic damage was  reduced in most of
the  treated groups.
Worth  noting is the effect of the lowest concentration
of PP-IX, (0.69 mM)  which caused a signiﬁcant decrease of
damage  in four of the ﬁve concentrations of CrO3 tested. In
comparison, 6.9 mM signiﬁcantly decreased the frequency
of  damage induced by 2 and 2.5 mM of the mutagen, and the
highest  concentration (69 mM)  only reduced the damage
induced by 2.5 mM.  Even so, 2.5 mM of CrO3 provoked high
mortality (61%) which could result in loss of information;
fferent concentrations of PP-IX and subsequently treated with 20 Gy of
ngle spots Twin spots Total spots
 m = 5 m = 5 m = 2
(2) 0.02 (1) 0.35 (14)
(126) 0.06 (5) 2.33 (187)
(93) w 0.08 (7) − 2.07 (166) −
(147) - 0.15 (12) − 2.67 (214) −
(122) − 0.07 (6) − 2.76 (221) −
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in combination with PP-IX, 69 mM increased viability by 7%
and  provoked a net effect of reducing 3 times inhibition of
the  genetic damage induced by CrO3 2.5 mM (p < 0.05).
Explaining the increase in mutation frequency obtained
in  the groups 69 + 1.25 and 2 mM CrO3 is not simple. How-
ever,  this increase could suggest a synergistic effect of
CrO3 plus the pro-oxidant action of PP-IX for its accumu-
lation generating superoxide, as suggested by Afonso et al.
[21].  PP-IX reacts with molecular oxygen-producing per-
oxide  radicals that cause lipid peroxidation and lead to
different  cell damage such as structural changes in the
cell  membrane, damage to proteins, inactivation of recep-
tors,  enzymes, and ion channels, all of which can lead to
cell  death [32]. Other studies have demonstrated that por-
phyrins  can bind to DNA via a speciﬁc insertion within only
one  strand of DNA, i.e., by hemi-intercalation [33] with a
binding  constant of around 106 M−1 [34,35]. In this way,
these  extra-helical structural elements could be a factor in
certain  pathways of mutagenesis [21].
The fact that the lowest concentration of PP-IX pro-
voked a signiﬁcant decrease in damage could be due to
the  fact that the porphyrin ring could make complexes
or act as a chelator, introducing the chromium into the
ring.  PP-IX has been reported to be able to bind other
metals such as zinc and nickel [36]. The different stud-
ies  on the role of ferrochelatase have revealed that this
enzyme catalyzes zinc as well as the iron chelating activity
of  protoporphyrin [14]. Ferrochelatase is known to catalyze
insertion of divalent transition metal ions other than iron
in  vitro, most notably zinc, but cobalt, nickel, and copper
have  also each been reported to act as substrates, although
species-speciﬁc differences have been noted [37–39]. Fer-
rochelatase could participate in the chelating chromium,
provoking a reduction in its mutagenic effect. The work
performed by Pimentel et al. [40] and Gaivão et al. [41]
have  demonstrated that the somatic mutation and recom-
bination test in Drosophila is a useful tool that detects the
very  low doses of alpha particles and the ROS induced
by oxidants agents, respectively; a possibility to explain
our  results is the ability of PP-IX to release electrons [42],
which  may  have inactivated the free radicals generated by
chromium  thereby avoiding DNA damage. The studies per-
formed  by Afonso et al. [21] provide evidence of the action
of  PP-IX in generating superoxide and hydrogen perox-
ide,  which causes activation of SOD and CAT enzymes that
help  to inactivate ROS produced by the chromium oxide-
reduction reactions. In contrast, Cruces et al. [43] found
that  a pretreatment with very low doses of sodium copper
chlorophyllin increased the somatic mutation frequency
induced by 10 Gy gamma  rays.
Results from the present work showed evidence indicat-
ing  that the lower concentration of PP-IX reduced genetic
damage of the radiomimetic agent CrO3. To evaluate the
ability  of PP-IX as a radical scavenger, we tested its action
against the effect of 20 Gy of gamma  rays (Table 4). The
comparison of the effect of PP-IX against the two agents
revealed that the action of PP-IX is more likely to be prefer-
able  through the formation of chemical complexes with
chromium rather than through decreasing reactive oxygen
species.  These ﬁndings placed PP-IX as an effective antimu-
tagen  at low doses.
[ports 1 (2014) 894–899
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